Grenova Announces Katherine Marrs as New CEO to Drive Innovation and Growth

RICHMOND, Va.--(BUSINESS WIRE)--Grenova, an industry leader in sustainable laboratory solutions, has appointed Katherine Marrs as its new Chief Executive Officer (CEO). Marrs succeeds Lane Major, who has served as CEO since 2023 and will continue to support Grenova as a member of the Board of Directors.

Marrs has been instrumental in driving Grenova’s growth strategy as the company’s Chief Commercial Officer for the past 16 months. Her leadership has been pivotal in expanding Grenova’s presence in the European market and enhancing its commitment to sustainability within the Life Sciences industry.

“We are at an exciting juncture, and I am honored to lead Grenova as we drive forward,” said Marrs. “I look forward to building on our team's accomplishments, enhancing our innovative product portfolio, advancing our automation and integration capabilities, and furthering our commitment to helping laboratories reduce their environmental footprint.”

Lane Major expressed his confidence in Marrs’ ability to lead Grenova into its next chapter. “Katherine has demonstrated remarkable vision and leadership during her time as Chief Commercial Officer. Her deep understanding of our business and commitment to innovation make her the perfect choice to lead Grenova.”

Ted Lundberg, Chairman of the Board of Directors for Grenova and Co-Founder of Peloton Equity, Grenova’s majority owner, said, “Katherine has shown remarkable skill in guiding Grenova’s commercial strategy and building a solid foundation for the company’s future. Her dedication, expertise, and strategic focus have proven invaluable, and we look forward to her continued success as CEO.”

As Grenova continues expanding its solutions, Marrs will leverage her expertise to enhance the company’s position in the market, foster partnerships that align with Grenova’s mission, and drive initiatives that further its dedication to environmental and economic responsibility.

About Grenova

Grenova® is a sustainability company dedicated to revolutionizing the Life Sciences industry by drastically reducing waste through the washing and reuse of consumable plastics. Grenova empowers laboratories worldwide to adopt eco-friendly solutions that enhance operational efficiency and maximize sustainability impact. The company is committed to providing solutions that lower carbon footprints, reduce waste, and conserve water. For more information, visit grenova.com.

About Peloton Equity

Peloton Equity (“Peloton”) is a growth capital investor with over 20 years of experience in the healthcare sector. Founded in 2014 as the successor firm to Ferrer Freeman & Company, Peloton specializes in partnering with healthcare companies that have the right leadership, market potential, and business model to drive growth. By leveraging its extensive healthcare network and disciplined investment approach, Peloton aims to transform lower-middle-market healthcare companies into industry leaders. The firm has invested in more than 35 healthcare companies and deployed over $900 million in capital. For more information, please visit pelotonequity.com.